Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06138691
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-26
First Post:
2023-11-07
Brief Title:
KET-RO Plus RO DBT for Treatment Resistant Depression
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Medication-assisted Psychotherapy Using Ketamine-enhanced Radically Open Dialectical Behavior Therapy RO DBT to Target Neural and Behavioral Mechanisms of Action in Adults with Moderate to Severe Depression
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
KET-RO
Brief Summary:
This pilot study will assess the safety and feasibility of intravenous IV ketamine combined with RO DBT in young adults with Treatment-Resistant Depression TRD In addition this study will develop and utilize innovative methodological approaches to demonstrate the feasibility of precision medicine with this type of therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None